Why Patients Self-Medicate With Leftover Antibiotics

Why Patients Self-Medicate With Leftover Antibiotics

Researchers surveyed adult patients in the waiting rooms of 6 public, safety-net primary care clinics and 2 private emergency departments in Texas and found that more than half of the respondents said they would use leftover antibiotics if they were feeling sick. Among the 546 volunteering patients surveyed, the most common situations that would inspire patients to use non-prescription antibiotics were having access to leftover antibiotics (50.4%), experiencing symptom improvement with prior use of antibiotics …

Read More
Liraglutide May Help Kids Under 12 Lose Weight

Liraglutide May Help Kids Under 12 Lose Weight

Liraglutide, the long-acting glucagon-like peptide-1 (GLP-1) drug, was approved for weight loss in among pediatric patients aged 12 and older who are obese. Recently, manufacturer Novo Nordisk found in a sponsored study that children between the ages of 6 and 12—a younger population—were able to reduce their body mass index by 7.4% in a 56-week trial using daily liraglutide injections, as published in the New England Journal of Medicine. The trial of 92 children met …

Read More
Simple Saline Drops Might Help Kids’ Colds

Simple Saline Drops Might Help Kids’ Colds

New research suggests that saline nasal drops can reduce the length of the common cold in children by 2 days, according to a press release from the European Respiratory Society. The trial included 407 children up to 6 years old who were either given hypertonic saline nasal drops or usual care when they developed a cold. Parents were instructed to apply 3 saline drops per nostril, a minimum of 4 times per day, until the …

Read More
RSV Vaccine Proves Its Worth Against Hospitalization Risk

RSV Vaccine Proves Its Worth Against Hospitalization Risk

Older adults who receive the respiratory syncytial virus (RSV) vaccine are 75% less likely to be hospitalized from RSV compared to those who are not vaccinated, according to a research letter in JAMA. By analyzing electronic medical record data from October 2023 to March 2024 for adults aged 60 years and older who were hospitalized with an acute respiratory illness, researchers selected a control group of 2,611 patients—who tested negative for RSV, COVID-19, and influenza—and …

Read More
New Epinephrine Nasal Spray Aims to Improve User Experience

New Epinephrine Nasal Spray Aims to Improve User Experience

A new epinephrine nasal spray has been approved by the Food and Drug Administration (FDA) for the treatment of allergic reactions, including anaphylaxis, in adult and pediatric patients who weight at least 66 pounds, according to an FDA press release. Until now, epinephrine has only been available for patients as an injection or auto-injection device. The agency says the new delivery mechanism addresses an unmet need in that some people who need urgent epinephrine treatment …

Read More
Whooping Cough Cases Rising Toward Previous Peaks

Whooping Cough Cases Rising Toward Previous Peaks

Health officials at the Centers for Disease Control and Prevention (CDC)  have reported elevated pertussis activity across multiple states, after months of warning Americans that pertussis—or whooping cough—was on pace to return pre-pandemic levels. Weekly reported cases are accelerating to the highest levels seen in the United States for years. For the month of July alone 2,410 cases were reported, bringing the total case count to 10,257 since January. This is 3.6 times higher than …

Read More
New Syphilis Home Screening Test Positioned to Raise Awareness

New Syphilis Home Screening Test Positioned to Raise Awareness

A new over-the-counter syphilis antibody test has received marketing authorization from the Food and Drug Administration (FDA). Branded as First To Know, the at-home screening test requires just a drop of blood and provides results within about 15 minutes, offering an early indication of a possible syphilis infection. However, any positive result must be further confirmed with laboratory testing. In a clinical trial involving 1,270 participants, the test accurately identified 99.5% of negative cases and …

Read More
Rise in Parvovirus B19 Causing Concern For Pregnant Women

Rise in Parvovirus B19 Causing Concern For Pregnant Women

The Centers for Disease Control and Prevention (CDC) issued a new health alert, calling attention to unusually high testing positivity rates for the highly transmissible parvovirus B19 as well as clusters of complications among individuals at high risk, such as those with sickle cell disease and pregnant women. Fetal infection can lead to myocarditis and aplastic crisis, and some cases of fetal anemia have required blood transfusions, according to NBC News. Also referred to as …

Read More
NY Warns of Antibiotic Resistance For Prophylactic Ciprofloxacin

NY Warns of Antibiotic Resistance For Prophylactic Ciprofloxacin

New York’s department of health issued an advisory last week cautioning healthcare organizations to stop prescribing the antibiotic ciprofloxacin as prophylactic treatment for people who have come in contact with someone who has meningococcal disease. The department created the recommendation based on an increase in antimicrobial resistance with ciprofloxacin. In New York City, 6 of the 35 (17%) isolates from patients diagnosed with invasive meningococcal disease from July 23, 2023, to July 22, 2024, were …

Read More
MIS-C Could Be Caused By Molecular Mistaken Identity  

MIS-C Could Be Caused By Molecular Mistaken Identity  

New research in Nature suggests that an autoimmune over-reaction could be what’s driving a pattern of multisystem inflammatory syndrome in children (MIS-C) after COVID-19 illness. Researchers looked at 199 blood samples from children with MIS-C and 45 control samples from children with COVID-19 but without MIS-C. About one-third of the MIS-C patients had autoantibodies for part of the human protein SNX8, which is found in the heart, lungs, kidneys, brain, skin, eyes, and gastrointestinal tract. …

Read More